临床路径病历质控的效果评价

EFFECTS OF QUALITY CONTROL FOR MEDICAL RECORDS OF CLINICAL PATHWAY

目的探讨临床路径病历质控的效果。方法把进入临床路径的急性ST段抬高型心肌梗死127例随机分为两组,进行临床路径病历质控的69例设为试验组,未行临床路径病历质控的58例设为对照组,比较两组住院时间、住院总费用和住院各分项费用的差别。结果试验组平均住院时间为(10.32±2.03)天,对照组为(12.10±2.96)天,试验组低于对照组,差异有统计学意义(p<0.05);试验组平均住院总费用为(52 349.94±16 944.22)元,对照组为(59 522.81±22 783.01)元,试验组低于对照组,差异有统计学意义(p<0.05)。两组分项费用中,试验组药费、护理费低于对照组,差异有统计学意义(p<0.05);其他分项费用差异无统计学意义(p>0.05)。结论临床路径的病历质控可以有效控制住院时间和住院费用,对临床路径的实施起到了进一步规范作用。

Objective To explore the application effect of quality control for medical records of clinical pathway. Methods The 127 clinical pathway patients with acute ST segment elevation myocardial infarction were randomly divided into two groups. 69 patients with clinical pathway quality control were taken as test group, while 58 patients without clinical pathway quality control were taken as control group. The hospitalization duration, total hospitalization expenses and various events expenses were compared between these two groups. Results The average hospitalization duration in test group was （ 10.32 ± 2.03 ） days, while that in control group was （12.10 ± 2.96） days, with statistically significant differences between the groups （p 〈 0.05 ）. The average hospitalization expense in the test group was （52,349.94 ± 16,944.22） yuan, while that in control group was （59,522.81 ± 22,783.01 ） yuan, with statistically significant differences between the groups （p 〈0.05）. Among various events of hospitalization expense, the medicine cost and nursing fee in the test group were lower than those in control group, with statistically significant differences （p 〈 0.05 ）, and no statistically significant differences were found in the other items （p 〉 0.05）. Conclusion The quality control for medical records of clinical pathway can effectively control the hospitalization duration and hospitalization expense, standardizing the implementation of clinical pathway.